Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
 Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT01908777
1:28:chronic_disease
Congenital long QT syndrome
2
[ "Congenital", "long", "QT", "syndrome" ]
[ 2, 2, 2, 2 ]
NCT02595372
1:22:treatment
Esomeprazole (Nexium)
2
[ "Esomeprazole", "(", "Nexium", ")" ]
[ 1, 1, 0, 0 ]
NCT02923921
,80:110:chronic_disease,112:135:chronic_disease
Clinically significant bleeding within two weeks prior to randomization (e.g., gastrointestinal (GI) bleeding, intracranial hemorrhage)
2
[ "Clinically", "significant", "bleeding", "within", "two", "weeks", "prior", "to", "randomization", "(", "e.g.", ",", "gastrointestinal", "(", "GI", ")", "bleeding", ",", "intracranial", "hemorrhage", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 2, 2, 0 ]
NCT02146924
45:52:chronic_disease,74:90:chronic_disease,104:128:chronic_disease,130:154:chronic_disease,156:174:chronic_disease,194:211:chronic_disease,215:234:chronic_disease,235:252:chronic_disease
Research participants with any uncontrolled illness including ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, poorly controlled pulmonary disease or psychiatric illness/social situations that would limit compliance with study requirements
2
[ "Research", "participants", "with", "any", "uncontrolled", "illness", "including", "ongoing", "or", "active", "infection", ",", "symptomatic", "congestive", "heart", "failure", ",", "unstable", "angina", "pectoris", ",", "cardiac", "arrhythmia", ",", "poorly", "cont...
[ 0, 0, 0, 0, 0, 2, 0, 0, 0, 2, 2, 0, 0, 2, 2, 2, 0, 2, 2, 2, 0, 2, 2, 0, 0, 0, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT01140087
1:18:cancer
Active malignancy
2
[ "Active", "malignancy" ]
[ 3, 3 ]
NCT02192359
48:100:treatment
Prospective participant is unable to undergo a magnetic resonance imaging (MRI) with contrast agent
2
[ "Prospective", "participant", "is", "unable", "to", "undergo", "a", "magnetic", "resonance", "imaging", "(", "MRI", ")", "with", "contrast", "agent" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 0, 0 ]
NCT02960113
22:55:treatment
Subjects who receive spinal and/or epidural anesthesia
2
[ "Subjects", "who", "receive", "spinal", "and/or", "epidural", "anesthesia" ]
[ 0, 0, 0, 1, 1, 1, 1 ]
NCT02089607
1:33:chronic_disease,,
Thoracoabdominal aortic aneurysm with a diameter ≥ 5.5 cm or 2 times the normal aortic diameter
2
[ "Thoracoabdominal", "aortic", "aneurysm", "with", "a", "diameter", "≥", "5.5", "cm", "or", "2", "times", "the", "normal", "aortic", "diameter" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00914823
1:12:treatment
medications used to treat the subject's reproductive condition
2
[ "medications", "used", "to", "treat", "the", "subject", "'s", "reproductive", "condition" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02553460
15:25:cancer
Patients with T-cell ALL
2
[ "Patients", "with", "T-cell", "ALL" ]
[ 0, 0, 3, 3 ]
NCT02266784
32:48:chronic_disease
Has a primary diagnosis of any Axis II Disorder
2
[ "Has", "a", "primary", "diagnosis", "of", "any", "Axis", "II", "Disorder" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 2 ]
NCT02555189
29:44:treatment,48:57:treatment,,144:154:treatment
Patients on stable doses of bisphosphonates or denosumab which have been started no less than 4 weeks prior to enrollment may continue on this medication
2
[ "Patients", "on", "stable", "doses", "of", "bisphosphonates", "or", "denosumab", "which", "have", "been", "started", "no", "less", "than", "4", "weeks", "prior", "to", "enrollment", "may", "continue", "on", "this", "medication" ]
[ 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02427581
39:61:cancer
Histologically confirmed diagnosis of invasive breast cancer
2
[ "Histologically", "confirmed", "diagnosis", "of", "invasive", "breast", "cancer" ]
[ 0, 0, 0, 0, 3, 3, 3 ]
NCT02920788
55:81:chronic_disease,93:103:chronic_disease,108:112:chronic_disease
Eligible participants may have other co-morbid stable neuropsychiatric disorders, including depression and PTSD
2
[ "Eligible", "participants", "may", "have", "other", "co-morbid", "stable", "neuropsychiatric", "disorders", ",", "including", "depression", "and", "PTSD" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 2, 0, 2 ]
NCT03084640
48:62:chronic_disease
Any concurrent uncontrolled illness, including mental illness or substance abuse, which in the opinion of the Investigator
2
[ "Any", "concurrent", "uncontrolled", "illness", ",", "including", "mental", "illness", "or", "substance", "abuse", ",", "which", "in", "the", "opinion", "of", "the", "Investigator" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02519322
80:83:treatment
following confirmation of their post-menopausal status, they can resume use of HRT during the study without use of a contraceptive method
2
[ "following", "confirmation", "of", "their", "post-menopausal", "status", ",", "they", "can", "resume", "use", "of", "HRT", "during", "the", "study", "without", "use", "of", "a", "contraceptive", "method" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02500381
16:36:treatment,
Stable dose of oral corticosteroids for at least 24 weeks
2
[ "Stable", "dose", "of", "oral", "corticosteroids", "for", "at", "least", "24", "weeks" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT01974609
27:47:chronic_disease
those with a diagnosis of cognitive impairment
2
[ "those", "with", "a", "diagnosis", "of", "cognitive", "impairment" ]
[ 0, 0, 0, 0, 0, 2, 2 ]
NCT01639508
1:23:chronic_disease
malabsorption syndrome
2
[ "malabsorption", "syndrome" ]
[ 2, 2 ]
NCT03093909
77:93:chronic_disease,95:106:chronic_disease,119:134:chronic_disease,136:155:chronic_disease,157:193:chronic_disease,195:219:chronic_disease,221:239:chronic_disease,244:281:chronic_disease
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, bradycardia, related to cardiac disease, bundle branch block, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study ...
2
[ "Uncontrolled", "intercurrent", "illness", "including", ",", "but", "not", "limited", "to", ",", "ongoing", "or", "active", "infection", ",", "bradycardia", ",", "related", "to", "cardiac", "disease", ",", "bundle", "branch", "block", ",", "symptomatic", "conges...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 0, 0, 0, 2, 2, 0, 2, 2, 2, 0, 2, 2, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02589977
1:15:chronic_disease
symptomatic HF
2
[ "symptomatic", "HF" ]
[ 2, 2 ]
NCT02169089
1:41:chronic_disease
Class III or IV Congestive Heart Failure
2
[ "Class", "III", "or", "IV", "Congestive", "Heart", "Failure" ]
[ 2, 2, 2, 2, 2, 2, 2 ]
NCT03058679
,25:40:treatment,,,88:98:treatment,102:112:treatment
Start or change dose of corticosteroids within 1 week of screening or a dose >20mg/day prednisone or equivalent
2
[ "Start", "or", "change", "dose", "of", "corticosteroids", "within", "1", "week", "of", "screening", "or", "a", "dose", ">", "20mg/day", "prednisone", "or", "equivalent" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1 ]
NCT03027388
74:84:treatment
Patients must be in adequate general medical health to safely tolerate a craniotomy
2
[ "Patients", "must", "be", "in", "adequate", "general", "medical", "health", "to", "safely", "tolerate", "a", "craniotomy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02950337
1:18:chronic_disease
Diabetes mellitus with end organ damage
2
[ "Diabetes", "mellitus", "with", "end", "organ", "damage" ]
[ 2, 2, 0, 0, 0, 0 ]
NCT02004275
20:36:cancer
Primary refractory multiple myeloma, where primary refractory multiple myeloma is defined as disease that is nonresponsive
2
[ "Primary", "refractory", "multiple", "myeloma", ",", "where", "primary", "refractory", "multiple", "myeloma", "is", "defined", "as", "disease", "that", "is", "nonresponsive" ]
[ 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02397889
25:43:chronic_disease,54:67:chronic_disease,71:95:chronic_disease
diagnosis of a lifetime psychotic disorder including schizophrenia or schizoaffective disorder
2
[ "diagnosis", "of", "a", "lifetime", "psychotic", "disorder", "including", "schizophrenia", "or", "schizoaffective", "disorder" ]
[ 0, 0, 0, 0, 2, 2, 0, 2, 0, 2, 2 ]
NCT01626079
,54:67:chronic_disease,,,,,,,,,,
The subject has had at least one hospitalization for heart failure in the 12 months prior to subject registration and/or a corrected brain natriuretic peptide (BNP) ≥300 pg/ml or corrected n-Terminal pro- brain natriuretic peptide NT-proBNP ≥1500 pg/ml measured within 90 days prior to subject registration (corrected re...
2
[ "The", "subject", "has", "had", "at", "least", "one", "hospitalization", "for", "heart", "failure", "in", "the", "12", "months", "prior", "to", "subject", "registration", "and/or", "a", "corrected", "brain", "natriuretic", "peptide", "(", "BNP", ")", "≥300", ...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0...
NCT02343549
18:30:treatment
Have undergone a brain biopsy via stereotactic or open technique
2
[ "Have", "undergone", "a", "brain", "biopsy", "via", "stereotactic", "or", "open", "technique" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT02407171
10:58:treatment,16:25:treatment,65:72:treatment,
have had prior treatments with Tyrosine Kinase Inhibitors (e.g. Tarceva) require only a 72-hour washout period prior to starting protocol treatment
2
[ "have", "had", "prior", "treatments", "with", "Tyrosine", "Kinase", "Inhibitors", "(", "e.g", ".", "Tarceva", ")", "require", "only", "a", "72-hour", "washout", "period", "prior", "to", "starting", "protocol", "treatment" ]
[ 0, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT00903266
31:37:chronic_disease
active participation in other stroke recovery trials testing experimental interventions
2
[ "active", "participation", "in", "other", "stroke", "recovery", "trials", "testing", "experimental", "interventions" ]
[ 0, 0, 0, 0, 2, 0, 0, 0, 0, 0 ]
NCT02311361
1:11:treatment,13:20:treatment,26:42:treatment
Intranasal, inhaled, and topical steroids
2
[ "Intranasal", ",", "inhaled", ",", "and", "topical", "steroids" ]
[ 1, 0, 1, 0, 0, 1, 1 ]
NCT00703105
33:44:treatment,,88:93:cancer,193:215:treatment
Patients must not have received irradiation for the four weeks prior to removal of the tumor and no previously irradiated tumor deposits may be used for tumor lysate in the development of the dendritic cell vaccine
2
[ "Patients", "must", "not", "have", "received", "irradiation", "for", "the", "four", "weeks", "prior", "to", "removal", "of", "the", "tumor", "and", "no", "previously", "irradiated", "tumor", "deposits", "may", "be", "used", "for", "tumor", "lysate", "in", "t...
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02366871
121:129:treatment
WOCBP must agree to follow instructions for method(s) of contraception for the duration of treatment with study drug(s) apixaban plus 5 half-lives of study drug apixaban (2.5 days) plus 30 days (duration of ovulatory cycle) for a total of 32.5 days post-treatment completion
2
[ "WOCBP", "must", "agree", "to", "follow", "instructions", "for", "method", "(", "s", ")", "of", "contraception", "for", "the", "duration", "of", "treatment", "with", "study", "drug", "(", "s", ")", "apixaban", "plus", "5", "half-lives", "of", "study", "dru...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02339233
1:15:chronic_disease,17:28:chronic_disease,30:37:chronic_disease,41:54:chronic_disease
cardiovascular, respiratory, bladder or renal disease unrelated to SCI
2
[ "cardiovascular", ",", "respiratory", ",", "bladder", "or", "renal", "disease", "unrelated", "to", "SCI" ]
[ 2, 0, 2, 0, 2, 0, 2, 2, 0, 0, 0 ]
NCT02826681
26:36:treatment,39:42:treatment,46:52:treatment,59:73:treatment
Previously randomized to Injectafer® (FCM or VIT-45) in a clinical trial
2
[ "Previously", "randomized", "to", "Injectafer®", "(", "FCM", "or", "VIT-45", ")", "in", "a", "clinical", "trial" ]
[ 0, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 1, 1 ]
NCT02371720
47:58:treatment,
Patients receiving automatic home delivery of medications since medication possession ratio is reflective of the patient initiation the refill when they have exhausted the home supply of HU
2
[ "Patients", "receiving", "automatic", "home", "delivery", "of", "medications", "since", "medication", "possession", "ratio", "is", "reflective", "of", "the", "patient", "initiation", "the", "refill", "when", "they", "have", "exhausted", "the", "home", "supply", "o...
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01789333
15:24:chronic_disease
Patients with nystagmus or any other condition that is severe enough to prevent steady gaze during the treatment
2
[ "Patients", "with", "nystagmus", "or", "any", "other", "condition", "that", "is", "severe", "enough", "to", "prevent", "steady", "gaze", "during", "the", "treatment" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02488967
12:27:chronic_disease
History of cardiac disease
2
[ "History", "of", "cardiac", "disease" ]
[ 0, 0, 2, 2 ]
NCT01928576
1:29:treatment,31:41:treatment,43:53:treatment,55:65:treatment,67:97:treatment,195:224:treatment,228:250:treatment
Prior therapy with anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, anti-CTLA-4 antibody therapies, any other antibody or drug specifically targeting T-cell co-stimulation or checkpoint pathways, DNA methyltransferase therapy or HDAC inhibitor therapy
2
[ "Prior", "therapy", "with", "anti-PD-1", ",", "anti-PD-L1", ",", "anti-PD-L2", ",", "anti-CD137", ",", "anti-CTLA-4", "antibody", "therapies", ",", "any", "other", "antibody", "or", "drug", "specifically", "targeting", "T-cell", "co-stimulation", "or", "checkpoint",...
[ 1, 1, 1, 1, 0, 1, 0, 1, 0, 1, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 1, 1 ]
NCT01474889
8:14:treatment,,
Use of RT-CGM (continuous glucose monitor) within last 4 weeks
2
[ "Use", "of", "RT-CGM", "(", "continuous", "glucose", "monitor", ")", "within", "last", "4", "weeks" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02851290
1:18:chronic_disease
Genetic syndromes
2
[ "Genetic", "syndromes" ]
[ 2, 2 ]
NCT00357565
1:25:treatment,
Myeloablative transplant within the last 6 months
2
[ "Myeloablative", "transplant", "within", "the", "last", "6", "months" ]
[ 1, 1, 0, 0, 0, 0, 0 ]
NCT02263729
6:23:chronic_disease,25:39:chronic_disease,41:46:chronic_disease,50:57:chronic_disease
Have diabetes mellitus, cardiovascular, renal or hepatic co-morbidities
2
[ "Have", "diabetes", "mellitus", ",", "cardiovascular", ",", "renal", "or", "hepatic", "co-morbidities" ]
[ 0, 2, 2, 0, 2, 0, 2, 0, 2, 0 ]
NCT03179397
10:28:treatment
Previous refractive surgery
2
[ "Previous", "refractive", "surgery" ]
[ 0, 1, 1 ]
NCT02394535
17:27:treatment
patients taking cimetidine must have this drug discontinued
2
[ "patients", "taking", "cimetidine", "must", "have", "this", "drug", "discontinued" ]
[ 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02172651
21:43:cancer
History of prior or synchronous malignancy
2
[ "History", "of", "prior", "or", "synchronous", "malignancy" ]
[ 0, 0, 0, 0, 3, 3 ]
NCT02530463
31:38:treatment,54:64:treatment,,91:121:treatment
Patients who are on high dose steroid (equivalent of prednisone more than 10 mg a day) or immune suppression medications
2
[ "Patients", "who", "are", "on", "high", "dose", "steroid", "(", "equivalent", "of", "prednisone", "more", "than", "10", "mg", "a", "day", ")", "or", "immune", "suppression", "medications" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02061293
1:8:treatment,10:25:treatment,27:33:treatment,38:46:treatment,
Cocaine, psychostimulant, opioid, or cannabis dependence (past 12 months)
2
[ "Cocaine", ",", "psychostimulant", ",", "opioid", ",", "or", "cannabis", "dependence", "(", "past", "12", "months", ")" ]
[ 1, 0, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT02128802
10:26:treatment
Previous renal transplant
2
[ "Previous", "renal", "transplant" ]
[ 0, 1, 1 ]
NCT02531295
8:23:treatment,
Recent hospitalization in the last 90 days
2
[ "Recent", "hospitalization", "in", "the", "last", "90", "days" ]
[ 0, 1, 0, 0, 0, 0, 0 ]
NCT02496663
38:60:treatment
Patients who are receiving any other investigational agents
2
[ "Patients", "who", "are", "receiving", "any", "other", "investigational", "agents" ]
[ 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT01620216
24:35:treatment,
Discontinuation of any medications known to contribute significantly to the risk of QT prolongation
2
[ "Discontinuation", "of", "any", "medications", "known", "to", "contribute", "significantly", "to", "the", "risk", "of", "QT", "prolongation" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03029806
1:13:treatment,
Decongestant use in the past 2 weeks
2
[ "Decongestant", "use", "in", "the", "past", "2", "weeks" ]
[ 1, 0, 0, 0, 0, 0, 0 ]
NCT03153319
1:26:chronic_disease,34:46:chronic_disease,48:63:chronic_disease
Hematologic abnormalities (e.g., pancytopenia, aplastic anemia)
2
[ "Hematologic", "abnormalities", "(", "e.g.", ",", "pancytopenia", ",", "aplastic", "anemia", ")" ]
[ 2, 2, 0, 0, 0, 2, 0, 2, 2, 0 ]
NCT02657993
6:12:cancer
Past cancer
2
[ "Past", "cancer" ]
[ 0, 3 ]
NCT02286687
12:42:chronic_disease,44:65:chronic_disease,69:84:chronic_disease,,130:137:treatment
History of cerebrovascular accident (CVA), myocardial infarction or unstable angina within the previous 6 months before starting therapy
2
[ "History", "of", "cerebrovascular", "accident", "(", "CVA", ")", ",", "myocardial", "infarction", "or", "unstable", "angina", "within", "the", "previous", "6", "months", "before", "starting", "therapy" ]
[ 0, 0, 2, 2, 2, 0, 0, 0, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02356861
48:54:cancer
Presence of a life-threatening disease such as cancer
2
[ "Presence", "of", "a", "life-threatening", "disease", "such", "as", "cancer" ]
[ 0, 0, 0, 0, 0, 0, 0, 3 ]
NCT02481310
27:56:chronic_disease,60:72:treatment,135:143:treatment
Patients who have a known gastrointestinal (GI) disease or GI procedure that could interfere with the oral absorption or tolerance of ixazomib including difficulty swallowing
2
[ "Patients", "who", "have", "a", "known", "gastrointestinal", "(", "GI", ")", "disease", "or", "GI", "procedure", "that", "could", "interfere", "with", "the", "oral", "absorption", "or", "tolerance", "of", "ixazomib", "including", "difficulty", "swallowing" ]
[ 0, 0, 0, 0, 0, 2, 2, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT02496663
129:153:chronic_disease,155:179:chronic_disease,181:206:chronic_disease
Any clinically important abnormalities in rhythm, conduction or morphology of resting electrocardiography (ECG) (e.g., complete left bundle branch block, third degree heart block, second degree heart block)
2
[ "Any", "clinically", "important", "abnormalities", "in", "rhythm", ",", "conduction", "or", "morphology", "of", "resting", "electrocardiography", "(", "ECG", ")", "(", "e.g.", ",", "complete", "left", "bundle", "branch", "block", ",", "third", "degree", "heart",...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 2, 2, 2, 2, 0, 2, 2, 2, 2, 0 ]
NCT02401347
30:41:treatment,45:54:treatment,,137:155:treatment
If prior platinum agent (eg, carboplatin or cisplatin) has been administered, no evidence of progression, or within 8 weeks of stopping platinum treatment
2
[ "If", "prior", "platinum", "agent", "(", "eg", ",", "carboplatin", "or", "cisplatin", ")", "has", "been", "administered", ",", "no", "evidence", "of", "progression", ",", "or", "within", "8", "weeks", "of", "stopping", "platinum", "treatment" ]
[ 0, 0, 1, 1, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00819208
10:22:treatment,41:50:treatment,55:68:cancer
No prior radiotherapy as a component of treatment for primary tumor
2
[ "No", "prior", "radiotherapy", "as", "a", "component", "of", "treatment", "for", "primary", "tumor" ]
[ 0, 0, 1, 0, 0, 0, 0, 1, 0, 3, 3 ]
NCT02764801
25:48:treatment
who have received prior radioembolization (Y90) of the lesion of interest
2
[ "who", "have", "received", "prior", "radioembolization", "(", "Y90", ")", "of", "the", "lesion", "of", "interest" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT01407809
1:18:chronic_disease
Visual field loss
2
[ "Visual", "field", "loss" ]
[ 2, 2, 2 ]
NCT02578732
15:31:chronic_disease,54:65:treatment,194:197:chronic_disease,199:210:chronic_disease,215:226:chronic_disease
Patients with active infection or fever (patients on antibiotics for infection or patients getting over a cold or seasonal virus are not excluded), or known historical or active infection with HIV, hepatitis B, or hepatitis C
2
[ "Patients", "with", "active", "infection", "or", "fever", "(", "patients", "on", "antibiotics", "for", "infection", "or", "patients", "getting", "over", "a", "cold", "or", "seasonal", "virus", "are", "not", "excluded", ")", ",", "or", "known", "historical", ...
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 2, 0, 0, 0, 0 ]
NCT01849146
1:35:chronic_disease,57:91:treatment,136:164:treatment
Human immunodeficiency virus (HIV)-positive patients on combination antiretroviral therapy are ineligible because of the potential for pharmacokinetic interactions with AZD1775 (MK-1775)
2
[ "Human", "immunodeficiency", "virus", "(", "HIV", ")", "-positive", "patients", "on", "combination", "antiretroviral", "therapy", "are", "ineligible", "because", "of", "the", "potential", "for", "pharmacokinetic", "interactions", "with", "AZD1775", "(", "MK-1775", "...
[ 2, 2, 2, 2, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT01644591
89:111:cancer
Patients are excluded if there is radiographic or cerebrospinal fluid (CSF) evidence of leptomeningeal disease
2
[ "Patients", "are", "excluded", "if", "there", "is", "radiographic", "or", "cerebrospinal", "fluid", "(", "CSF", ")", "evidence", "of", "leptomeningeal", "disease" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3 ]
NCT02584647
77:103:treatment
these patients are at increased risk of lethal infections when treated with marrow suppressive therapy
2
[ "these", "patients", "are", "at", "increased", "risk", "of", "lethal", "infections", "when", "treated", "with", "marrow", "suppressive", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02367196
16:22:cancer,,
Prior systemic cancer-directed treatments or investigational modalities ≤ 5 half lives or 4 weeks prior to starting CC-90002, whichever is shorter
2
[ "Prior", "systemic", "cancer-directed", "treatments", "or", "investigational", "modalities", "≤", "5", "half", "lives", "or", "4", "weeks", "prior", "to", "starting", "CC-90002", ",", "whichever", "is", "shorter" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02338232
1:29:treatment
Regimens for transplantation
2
[ "Regimens", "for", "transplantation" ]
[ 1, 1, 1 ]
NCT02366871
20:54:treatment,56:62:treatment,64:68:treatment
Concomitant use of dual strong inhibitors or inducers (CYP3A4, P-gp)
2
[ "Concomitant", "use", "of", "dual", "strong", "inhibitors", "or", "inducers", "(", "CYP3A4", ",", "P-gp", ")" ]
[ 0, 0, 0, 1, 1, 1, 1, 1, 0, 1, 0, 1, 0 ]
NCT02053363
8:30:chronic_disease
Active intravascular clotting
2
[ "Active", "intravascular", "clotting" ]
[ 0, 2, 2 ]
NCT02911792
12:18:cancer
History of cancer
2
[ "History", "of", "cancer" ]
[ 0, 0, 3 ]
NCT02188121
18:42:treatment,72:78:treatment,82:85:treatment,
Receiving active cardiovascular treatment, defined as receiving both a statin or ARB in the past three months
2
[ "Receiving", "active", "cardiovascular", "treatment", ",", "defined", "as", "receiving", "both", "a", "statin", "or", "ARB", "in", "the", "past", "three", "months" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0 ]
NCT02913430
1:17:cancer,
Brain metastasis is allowed if previously treated, stable and off steroids for a minimum of 56 days
2
[ "Brain", "metastasis", "is", "allowed", "if", "previously", "treated", ",", "stable", "and", "off", "steroids", "for", "a", "minimum", "of", "56", "days" ]
[ 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03075826
14:26:treatment,62:73:treatment,91:103:treatment,,
have had any chemotherapy (investigational or FDA approved) (hydroxyurea is permitted) or radiotherapy within 2 weeks prior to study entry or those who have not recovered from adverse events due to agents administered more than 2 weeks earlier
2
[ "have", "had", "any", "chemotherapy", "(", "investigational", "or", "FDA", "approved", ")", "(", "hydroxyurea", "is", "permitted", ")", "or", "radiotherapy", "within", "2", "weeks", "prior", "to", "study", "entry", "or", "those", "who", "have", "not", "recov...
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02332668
,,,42:47:cancer
between 3 years and <18 years of age for rrcHL participants
2
[ "between", "3", "years", "and", "<", "18", "years", "of", "age", "for", "rrcHL", "participants" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0 ]
NCT01715220
,,,,,135:144:treatment,150:174:treatment,178:185:treatment
Patients with right upper quadrant abdominal pain of less than 24 hours' duration between ages 18 and 60 years of age will be offered treatment with sublingual nitroglycerin or placebo
2
[ "Patients", "with", "right", "upper", "quadrant", "abdominal", "pain", "of", "less", "than", "24", "hours", "'", "duration", "between", "ages", "18", "and", "60", "years", "of", "age", "will", "be", "offered", "treatment", "with", "sublingual", "nitroglycerin"...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 1 ]
NCT02487082
158:169:treatment
Drugs that induce or inhibit cytochrome P450 2D6 and cytochrome P450 3A4 (enzymes important for drug metabolism) will be allowed because any effects of such medications are likely to be lost in individual variability due to genetic polymorphisms
2
[ "Drugs", "that", "induce", "or", "inhibit", "cytochrome", "P450", "2D6", "and", "cytochrome", "P450", "3A4", "(", "enzymes", "important", "for", "drug", "metabolism", ")", "will", "be", "allowed", "because", "any", "effects", "of", "such", "medications", "are"...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02816736
9:33:chronic_disease
Complex congenital heart disease
2
[ "Complex", "congenital", "heart", "disease" ]
[ 0, 2, 2, 2 ]
NCT02582775
12:25:chronic_disease
History of HIV infection
2
[ "History", "of", "HIV", "infection" ]
[ 0, 0, 2, 2 ]
NCT02133196
77:99:treatment
Patients who have decreased immune competence may be less responsive to the experimental treatment and more susceptible to its toxicities
2
[ "Patients", "who", "have", "decreased", "immune", "competence", "may", "be", "less", "responsive", "to", "the", "experimental", "treatment", "and", "more", "susceptible", "to", "its", "toxicities" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT01760655
,16:41:chronic_disease
Greater than 3 cytogenetic abnormalities or any one of the following cytogenetic abnormalities
2
[ "Greater", "than", "3", "cytogenetic", "abnormalities", "or", "any", "one", "of", "the", "following", "cytogenetic", "abnormalities" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01959698
1:36:chronic_disease,47:80:chronic_disease,91:127:chronic_disease
Hepatitis B surface antigen (HBsAg) negative, hepatitis B core antibody (HBcAb) negative, hepatitis B surface antibody (HBsAb) positive patients
2
[ "Hepatitis", "B", "surface", "antigen", "(", "HBsAg", ")", "negative", ",", "hepatitis", "B", "core", "antibody", "(", "HBcAb", ")", "negative", ",", "hepatitis", "B", "surface", "antibody", "(", "HBsAb", ")", "positive", "patients" ]
[ 2, 2, 2, 2, 2, 0, 0, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02320292
18:23:chronic_disease,34:42:treatment,60:68:treatment
Subjects who are HBsAg negative, anti-HBs positive, and/or anti-HBc positive, but viral DNA negative are eligible
2
[ "Subjects", "who", "are", "HBsAg", "negative", ",", "anti-HBs", "positive", ",", "and/or", "anti-HBc", "positive", ",", "but", "viral", "DNA", "negative", "are", "eligible" ]
[ 0, 0, 0, 2, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02527265
17:43:treatment,
Exposure to any investigational product(s) in the past 3 months or 5 half-lives, whichever is more
2
[ "Exposure", "to", "any", "investigational", "product", "(", "s", ")", "in", "the", "past", "3", "months", "or", "5", "half-lives", ",", "whichever", "is", "more" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02233868
40:49:allergy_name
Have a history of allergic reaction to lidocaine (self-report, medical history)
2
[ "Have", "a", "history", "of", "allergic", "reaction", "to", "lidocaine", "(", "self-report", ",", "medical", "history", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0 ]
NCT01696734
24:35:chronic_disease
clinically significant bradycardia
2
[ "clinically", "significant", "bradycardia" ]
[ 0, 0, 2 ]
NCT01742299
48:66:treatment
Patient has been permanently discontinued from imatinib treatment in the parent study due to unacceptable toxicity, non-compliance to study procedures, withdrawal of consent or any other reason
2
[ "Patient", "has", "been", "permanently", "discontinued", "from", "imatinib", "treatment", "in", "the", "parent", "study", "due", "to", "unacceptable", "toxicity", ",", "non-compliance", "to", "study", "procedures", ",", "withdrawal", "of", "consent", "or", "any", ...
[ 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01659203
23:73:cancer
Histologically proven primary soft tissue sarcoma of the retroperitoneum
2
[ "Histologically", "proven", "primary", "soft", "tissue", "sarcoma", "of", "the", "retroperitoneum" ]
[ 0, 0, 3, 3, 3, 3, 3, 3, 3 ]
NCT02565966
,,,17:33:treatment
diet 3 -4 weeks prior to surgery
2
[ "diet", "3", "-4", "weeks", "prior", "to", "surgery" ]
[ 0, 0, 0, 0, 1, 1, 1 ]
NCT02269293
46:58:treatment
Patients must be willing and able to swallow oral tablets
2
[ "Patients", "must", "be", "willing", "and", "able", "to", "swallow", "oral", "tablets" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT01850758
1:19:chronic_disease
Bleeding disorders
2
[ "Bleeding", "disorders" ]
[ 2, 2 ]
NCT02912572
16:24:treatment
The effects of avelumab on the developing human fetus are unknown
2
[ "The", "effects", "of", "avelumab", "on", "the", "developing", "human", "fetus", "are", "unknown" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02913430
,,31:46:cancer
ALP ≤ 5X ULN in patients with bone metastases
2
[ "ALP", "≤", "5X", "ULN", "in", "patients", "with", "bone", "metastases" ]
[ 0, 0, 0, 0, 0, 0, 0, 3, 3 ]
NCT02524275
31:64:treatment
Simultaneous participation in other therapeutic clinical trials will not be allowed
2
[ "Simultaneous", "participation", "in", "other", "therapeutic", "clinical", "trials", "will", "not", "be", "allowed" ]
[ 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0 ]
NCT02343042
13:15:cancer
Symptomatic MM, based on IMWG guidelines
2
[ "Symptomatic", "MM", ",", "based", "on", "IMWG", "guidelines" ]
[ 0, 3, 0, 0, 0, 0, 0 ]
NCT02768727
12:28:chronic_disease
History of seizure disorder
2
[ "History", "of", "seizure", "disorder" ]
[ 0, 0, 2, 2 ]
NCT01584076
1:10:treatment,
Treatment with topical atropine within the past 4 weeks
2
[ "Treatment", "with", "topical", "atropine", "within", "the", "past", "4", "weeks" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02500602
52:56:chronic_disease
Meet DSM-5 criteria for current (i.e., last month) PTSD
2
[ "Meet", "DSM-5", "criteria", "for", "current", "(", "i.e.", ",", "last", "month", ")", "PTSD" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]